ArticleFrontiers in physiology2025
Arterial compliance is improved via enteral serine protease inhibition in experimental trauma/hemorrhagic shock.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Systemic hypotension remains a challenge in trauma/hemorrhagic shock (T/HS). Despite intensive vasopressor and fluid therapy, mean arterial blood pressure (MAP) may become refractory to treatment. Arterial compliance (AC) is a critical determinant of arterial hemodynamics but is often overlooked in acute shock states. Considering previous findings on the benefits of enteral protease inhibition in preserving vascular resistance after T/HS, this study investigated both the role of AC and the effects of enteral protease inhibition on AC in T/HS. Methods: Wistar rats underwent experimental T/HS by laparotomy and exsanguination to induce a MAP of ∼40 mmHg for 90 min. Animals were randomized into three groups corresponding to the intervention: shed whole blood (WB), Lactated Ringer's (LR), and LR with enteral gabexate mesilate treatment (LR+GM). Resuscitation (120-min period) was initiated by fluid reperfusion with a goal MAP of 65 mmHg. AC was measured via pulse wave velocity (PWV), passive pressure myography, and atomic force microscopy (AFM), with healthy donor arteries for comparison. Results: PWV increased by ∼15% in all groups after shock. After resuscitation, LR-only animals maintained high PWVs, but significantly lower diastolic pressures (27 mmHg) compared to GM-treated (37 mmHg; p < 0.05) and those reperfused with WB (52 mmHg; p < 0.01). T/HS arteries, particularly the untreated LR arteries, exhibited leftward shifts in circumferential tension-strain curves. LR arteries exhibited higher tangent moduli (5 N/m; p < 0.01) at low physiological stresses, which was corroborated by reduced opening angles, increased mechanical stiffness, alterations in the extracellular matrix, and increased MMP/elastase-like activity. LR+GM and WB arteries displayed elastic moduli and vascular structures more similar to those of healthy arteries. Conclusion: Experimental T/HS results in impaired AC, which is partially attenuated by enteral GM administration. Vascular biomechanical impairment may underlie the unrestored MAP in fulminant shock. By targeting modulators of AC, with enteral serine protease inhibition as an adjunct intervention, hemodynamic stability and patient outcomes may be improved in T/HS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.